相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis
Chia-Hsien Chen et al.
FRONTIERS IN PHARMACOLOGY (2022)
Ricks of Hip and Nonvertehral Fractures in Patients With Ciku G3a-G5D: A Systematic Review and Meta-analysis
Tatiane Vilaca et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial
Ken Iseri et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis
Charat Thongprayoon et al.
ARCHIVES OF OSTEOPOROSIS (2019)
Effect of Bisphosphonates on Bone Health in Adult Renal Transplant Patients: Beyond the First Year Posttransplant-A Systematic Review and Meta-Analysis
Alyssa Lip et al.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE (2019)
Safety and efficacy of denosumab in osteoporotic hemodialysed patients
Francescaromana Festuccia et al.
JOURNAL OF NEPHROLOGY (2017)
Management of Osteoporosis in Chronic Kidney Disease
Kosaku Nitta et al.
INTERNAL MEDICINE (2017)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease A Systematic Review and Meta-analysis
Lisa M. Wilson et al.
ANNALS OF INTERNAL MEDICINE (2017)
Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: A Randomized Controlled Trial
M. Bonani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis
Stephanie M. Toth-Manikowski et al.
CLINICAL TRANSPLANTATION (2016)
Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease
Sun Moon Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation A Meta-Analysis
Shun-Li Kan et al.
MEDICINE (2016)
Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials
J. Wang et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report
Atsushi Nishikawa et al.
CLINICAL INTERVENTIONS IN AGING (2016)
Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients
Ana Sanchez-Escuredo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management
Paul D. Miller
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
An Open-Label, Prospective Pilot Clinical Study of Denosumab for Severe Hyperparathyroidism in Patients With Low Bone Mass Undergoing Dialysis
Chien-Liang Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
High rates of death and hospitalization follow bone fracture among hemodialysis patients
Francesca Tentori et al.
KIDNEY INTERNATIONAL (2014)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Clinical Efficacy and Safety of Pamidronate Therapy on Bone Mass Density in Early Post-Renal Transplant Period: A Meta-Analysis of Randomized Controlled Trials
Zijie Wang et al.
PLOS ONE (2014)
Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches
Felicia Cosman
CURRENT OSTEOPOROSIS REPORTS (2014)
A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation
K. T. Smerud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
A single-dose study of denosumab in patients with various degrees of renal impairment
Geoffrey A. Block et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Effect of Risedronate on Bone in Renal Transplant Recipients
Maria Coco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Effects of Denosumab on Fracture and Bone Mineral Density by Level of Kidney Function
Sophie A. Jamal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant
J. -V. Torregrosa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
被撤回的出版物: Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study (Retracted article. See vol. 68, pg. 333, 2016)
Sophie A. Jamal et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled Trial
Nigel D. Toussaint et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Open-Label Trial: Effect of Weekly Risedronate Immediately After Transplantation in Kidney Recipients
Jose-Vicente Torregrosa et al.
TRANSPLANTATION (2010)
Effect of Pamidronate on Bone Loss After Kidney Transplantation: A Randomized Trial
Stephen B. Walsh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Increasing Options for the Treatment of Osteoporosis
Sundeep Khosla
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effect of teriparatide on early bone loss after kidney transplantation
D. Cejka et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
The effect of raloxifene treatment in postmenopausal women with CKD
Areef Ishani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Alendronate Is Effective to Treat Bone Loss in Renal Transplantation Recipients
G. Lan et al.
TRANSPLANTATION PROCEEDINGS (2008)
Treatment of renal transplant recipients with low bone mineral density: A randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol
S. Trabulus et al.
TRANSPLANTATION PROCEEDINGS (2008)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Renal function and risk of hip and vertebral fractures in older women
Kristine E. Ensrud et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Relationship between moderate to severe kidney disease and hip fracture in the United States
Thomas L. Nickolas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of short-term alendronate on bone mineral density in haemodialysis patients
JB Wetmore et al.
NEPHROLOGY (2005)
A prospective randomized study for prevention of postrenal transplantation bone loss
AE El-Agroudy et al.
KIDNEY INTERNATIONAL (2005)
Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials
SC Palmer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate
JR Jeffery et al.
TRANSPLANTATION (2003)
Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate
M Coco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Alendronate for treatment of renal transplant patients with osteoporosis
JV Torregrosa et al.
TRANSPLANTATION PROCEEDINGS (2003)
Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis
E Hernández et al.
KIDNEY INTERNATIONAL (2003)
Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation
SLS Fan et al.
KIDNEY INTERNATIONAL (2003)
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation
M Haas et al.
KIDNEY INTERNATIONAL (2003)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Alendronate increases bone mineral density in long-term renal transplant recipients
M Koc et al.
TRANSPLANTATION PROCEEDINGS (2002)
Alendronate prevents further bone loss in renal transplant recipients
S Giannini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Economic implications of hip fracture: Health service use, institutional care and cost in Canada
ME Wiktorowicz et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Increased risk of hip fracture among patients with end-stage renal disease
AM Alem et al.
KIDNEY INTERNATIONAL (2000)
分享论文
